These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18936690)

  • 1. Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression.
    Trpkov K; Zhang J; Chan M; Eigl BJ; Yilmaz A
    Am J Surg Pathol; 2009 Feb; 33(2):233-40. PubMed ID: 18936690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
    Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
    Gonzalgo ML; Bastian PJ; Mangold LA; Trock BJ; Epstein JI; Walsh PC; Partin AW
    Urology; 2006 Jan; 67(1):115-9. PubMed ID: 16413345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
    Sim HG; Telesca D; Culp SH; Ellis WJ; Lange PH; True LD; Lin DW
    J Urol; 2008 May; 179(5):1775-9. PubMed ID: 18343432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
    Nanda A; Chen MH; Renshaw AA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
    Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
    J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
    Whittemore DE; Hick EJ; Carter MR; Moul JW; Miranda-Sousa AJ; Sexton WJ
    J Urol; 2008 Feb; 179(2):516-22; discussion 522. PubMed ID: 18076949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in lymph node-positive prostate cancer.
    Hofer MD; Kuefer R; Huang W; Li H; Bismar TA; Perner S; Hautmann RE; Sanda MG; Gschwend JE; Rubin MA
    Urology; 2006 May; 67(5):1016-21. PubMed ID: 16698361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
    Tollefson MK; Leibovich BC; Slezak JM; Zincke H; Blute ML
    J Urol; 2006 Feb; 175(2):547-51. PubMed ID: 16406993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative PSA is still predictive of cancer volume and grade in late PSA era.
    Figler BD; Reuther AM; Dhar N; Levin H; Magi-Galluzzi C; Zhou M; Klein EA
    Urology; 2007 Oct; 70(4):711-6. PubMed ID: 17991542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
    Khatami A; Hugosson J; Wang W; Damber JE
    Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
    Patel AA; Chen MH; Renshaw AA; D'Amico AV
    JAMA; 2007 Oct; 298(13):1533-8. PubMed ID: 17911498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.
    Boorjian SA; Karnes RJ; Crispen PL; Rangel LJ; Bergstralh EJ; Sebo TJ; Blute ML
    J Urol; 2009 Jan; 181(1):95-104; discussion 104. PubMed ID: 19012937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
    Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.